Gujarat Terce Laboratories Limited reported earnings results for the third quarter and nine months ended December 31, 2021. For the third quarter, the company reported sales was INR 107.46 million compared to INR 70.84 million a year ago. Revenue was INR 108.16 million compared to INR 71.57 million a year ago. Net income was INR 4.77 million compared to net loss of INR 0.748 million a year ago. Basic earnings per share from continuing operations was INR 0.64 compared to basic loss per share from continuing operations of INR 0.1 a year ago. Diluted earnings per share from continuing operations was INR 0.64 compared to diluted loss per share from continuing operations of INR 0.1 a year ago.
For the nine months, sales was INR 308.09 million compared to INR 192.63 million a year ago. Revenue was INR 310.23 million compared to INR 194.9 million a year ago. Net income was INR 25.31 million compared to net loss of INR 5.32 million a year ago. Basic earnings per share from continuing operations was INR 3.41 compared to basic loss per share from continuing operations of INR 0.72 a year ago. Diluted earnings per share from continuing operations was INR 3.41 compared to diluted loss per share from continuing operations of INR 0.72 a year ago.